tiprankstipranks
Trending News
More News >
Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
US Market
Advertisement

Enlivex (ENLV) Drug Pipeline

Compare
467 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Allocetra
Arthritis, Psoriatic
Phase I
Recruiting
Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
Jul 07, 2024
Allocetra
Osteoarthritis, Knee
Phase I/II
Active Not Recruiting
Study of Intra-articular Allocetra in Knee Osteoarthritis
Jan 22, 2024
Allocetra-Ots
Urinary Tract Infections, Sepsis, Community-Acquired Pneumonia, Cholecystitis, Acute, Cholangitis Acute, Intraabdominal Infections
Phase II
Completed
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
Oct 26, 2020

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Enlivex Therapeutics Ltd (ENLV) have in its pipeline
      ENLV is currently developing the following drugs: Allocetra, Allocetra, Allocetra-Ots. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis